Status:
ACTIVE_NOT_RECRUITING
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors
Lead Sponsor:
Menoufia University
Conditions:
Bladder Cancer
Eligibility:
All Genders
25-80 years
Phase:
NA
Brief Summary
Prospective controlled study randomized comparing bipolar enbloc versus thulium enbloc for bladder tumours
Detailed Description
Bladder cancer is the ninth most prevalent cancer worldwide and the 2nd most common urologic cancer in the last two decades after cancer prostate . Most bladder cancers attributed to exposure to envi...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with NMIBC
- Bladder tumors\<4 cm in CT.
- Resectable bladder tumors.
- Age \<80 years.
- Exclusion criteria :
- Bladder tumours \> 4cm .
- Metastatic bladder tumors.
- Patients with carcinoma in situ CIS .
- Patients with coagulopathies.
- Domal bladder tumors.
Exclusion
Key Trial Info
Start Date :
June 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 29 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06119724
Start Date
June 11 2023
End Date
December 29 2025
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menoufia university hospital
Shibīn al Kawm, Menoufia, Egypt